Literature DB >> 2529890

The MTT assay underestimates the growth inhibitory effects of interferons.

S A Jabbar1, P R Twentyman, J V Watson.   

Abstract

The growth inhibitory effects of interferons, IFN-alpha and IFN-gamma on human lung cancer cell lines were studied using both a tetrazolium (MTT) colorimetric assay and direct cell counting. Significant discrepancies between the two assays were observed, the MTT assay consistently underestimating the growth inhibitory effects of the IFNs. There was no direct chemical effect of the IFNs on the tetrazolium reduction process. IFN treated cells showed increased cell size compared with control cells, although there was little or no change in cell cycle distribution. Mitochondrial activity was 30-50% greater in IFN-gamma treated cells (COR-L23) than the controls. Reduced formazan production per cell was observed in medium which had supported cell growth for several days. Differential 'medium conditioning' led to a difference in formazan production per cell between IFN and control cells and this was the major basis of the observed discrepancy. This discrepancy was not due to the differences in the glucose concentrations between these media. However, differences in pH between the media proved to be the major contributory factor of the discrepancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529890      PMCID: PMC2247113          DOI: 10.1038/bjc.1989.306

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS.

Authors:  T F SLATER; B SAWYER; U STRAEULI
Journal:  Biochim Biophys Acta       Date:  1963-11-08

2.  Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells.

Authors:  K PAUCKER; K CANTELL; W HENLE
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

3.  Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle.

Authors:  D Killander; P Lindahl; L Lundin; P Leary; I Gresser
Journal:  Eur J Immunol       Date:  1976-01       Impact factor: 5.532

4.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

5.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

6.  Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques.

Authors:  J V Watson
Journal:  Cytometry       Date:  1980-09

7.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

8.  Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast.

Authors:  F Balkwill; D Watling; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

9.  Monitoring the effect of anti-cancer drugs on L1210 cells by a mitochondrial probe, rhodamine-123.

Authors:  S D Bernal; H M Shapiro; L B Chen
Journal:  Int J Cancer       Date:  1982-08-15       Impact factor: 7.396

10.  The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.

Authors:  P R Twentyman; P Workman; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

View more
  31 in total

1.  The methylene blue colorimetric microassay for determining cell line response to growth factors.

Authors:  M F Dent; L Hubbold; H Radford; A P Wilson
Journal:  Cytotechnology       Date:  1995-02       Impact factor: 2.058

2.  Acid phosphatase: endpoint for in vitro toxicity tests.

Authors:  A Martin; M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

3.  Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.

Authors:  S P Cole; B M Campigotto; J G Johnson; B E Elliott
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; R Schönmayr; W Schachenmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

6.  Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels.

Authors:  Christopher A Ingraham; Gabriel C Park; Helen P Makarenkova; Kathryn L Crossin
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

7.  High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.

Authors:  Bin Lou; Xue-Ling Liao; Man-Ping Wu; Pei-Fang Cheng; Chun-Yan Yin; Zheng Fei
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.

Authors:  S B Sobottka; M R Berger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer.

Authors:  Fabiana Sélos Guerra; Daniel Alencar Rodrigues; Carlos Alberto Manssour Fraga; Patricia Dias Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

10.  Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival.

Authors:  Alessandra Ciucci; Ilaria De Stefano; Valerio Gaetano Vellone; Lucia Lisi; Carolina Bottoni; Giovanni Scambia; Gian Franco Zannoni; Daniela Gallo
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.